insights_auto
为什么 4DX 下跌了 4.42%?
深入探索chevron_right
4DX:ASX
4DMedical Ltd
AU$2.16
arrow_downward
-4.42%(-0.100) 1 天
11月20日, GMT+11 16:12:01 · AUD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 4DX 生成关键数据洞见…
开盘价
AU$2.25
最高价
AU$2.30
最低价
AU$2.12
市值
13.01亿
平均成交量
528.61万
成交量
432.35万
52 周最高价
AU$7.55
52 周最低价
AU$1.40
每股收益
-AU$0.38
流通股数
6.02亿
员工人数
181
开盘价
AU$2.25
最高价
AU$2.30
最低价
AU$2.12
市值
13.01亿
平均成交量
528.61万
成交量
432.35万
52 周最高价
AU$7.55
52 周最低价
AU$1.40
每股收益
-AU$0.38
流通股数
6.02亿
员工人数
181
新闻报道
来自网络来源和新闻合作伙伴
资料
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
4DMedical Ltd简介